Hi-Clearance Inc. (TPEX:1788)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
136.50
+0.50 (0.37%)
Apr 29, 2026, 10:59 AM CST
-3.53%
Market Cap 6.05B
Revenue (ttm) 4.28B
Net Income (ttm) 368.51M
Shares Out 44.52M
EPS (ttm) 8.27
PE Ratio 16.44
Forward PE n/a
Dividend 7.00 (5.17%)
Ex-Dividend Date Jun 23, 2025
Volume 36,997
Average Volume 27,038
Open 135.50
Previous Close 136.00
Day's Range 135.00 - 136.50
52-Week Range 135.00 - 145.00
Beta 0.10
RSI 44.96
Earnings Date Mar 30, 2026

About Hi-Clearance

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dentistry, oral surgery, thoracic, respiratory, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and, RO machines, and related consumables and drugs; interventional cardiology and radiology, and plastic surgery devices; dentistry consumables, implant materials, and equipment; and blood glucose monitors, and related consumables and nutrition products, as well as hemodialysis management services. It engages in the design and management of dialysi... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1989
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 1788
Full Company Profile

Financial Performance

In 2025, Hi-Clearance's revenue was 4.28 billion, an increase of 5.04% compared to the previous year's 4.07 billion. Earnings were 368.51 million, an increase of 2.45%.

Financial Statements

News

There is no news available yet.